SALT LAKE CITY, May 16 /PRNewswire/ -- Amedica Corporation announced
 today that it has successfully completed a private placement of its Series
 D Convertible Preferred Stock, raising $13.2 million in gross proceeds.
 With the closing of this financing round, Amedica has raised over $44
 million since November 2003. Creation Capital LLC served as the placement
 agent for the financing.
     Amedica plans to use the proceeds to continue the expansion of its
 manufacturing facilities for medical ceramics; continue product
 development; hire additional key personnel; continue to pursue patent
 protection for its technologies and products; and for working capital
 purposes.
     "We are very pleased with the financing which will provide additional
 resources for us to continue advancing our lead and pipeline products
 toward commercialization," said Ashok C. Khandkar, Chief Executive Officer
 of Amedica.
     Amedica Corporation is an emerging orthopedic implant company focused
 on using its ceramics technologies to develop and commercialize a broad
 range of innovative spine and joint implants for the growing orthopedic
 device market. Its product candidates include spinal and reconstructive hip
 and knee implants that may represent a new standard of care in total joint
 implants based on superior durability, performance and safety.
 
 

SOURCE Amedica Corporation